CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues
Total revenues	$ 10,143,290	$ 8,220,639
Cost of revenues	5,095,621	3,222,390
Gross profit	5,047,669	4,998,249
Operating expenses
Selling, general and administrative	4,945,450	4,640,912
Depreciation and amortization	845,016	679,171
Total operating expenses	5,790,466	5,320,083
Loss from operations	(742,797)	(321,834)
Other income
Interest income, net	584,197	14,336
Loss before income tax provision	(158,600)	(307,498)
Income tax provision	1,530	1,897
Net loss	$ (160,130)	$ (309,395)
Weighted average common shares
Basic	$ (0.00)	$ (0.01)
Diluted	$ (0.00)	$ (0.01)
Basic	52,403,454	51,818,676
Diluted	52,403,454	51,818,676
Plasma Industry [Member]
Revenues
Total revenues	$ 9,360,067	$ 7,394,364
Pharmaceutical Industry [Member]
Revenues
Total revenues	589,562	806,568
Other Revenue [Member]
Revenues
Total revenues	$ 193,661	$ 19,707